Sone Capital Management LLC Invests $27.75 Million in The Cooper Companies, Inc. $COO

Sone Capital Management LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm bought 387,030 shares of the medical device company’s stock, valued at approximately $27,754,000. Cooper Companies makes up approximately 2.1% of Sone Capital Management LLC’s investment portfolio, making the stock its 9th biggest position. Sone Capital Management LLC owned approximately 0.20% of Cooper Companies at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares in the last quarter. First Trust Advisors LP boosted its stake in Cooper Companies by 115.8% in the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after purchasing an additional 73,165 shares in the last quarter. Cresset Asset Management LLC bought a new stake in shares of Cooper Companies during the second quarter worth $291,000. Cerity Partners LLC grew its holdings in shares of Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in shares of Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after buying an additional 973 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $75.80 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The stock has a market capitalization of $14.78 billion, a P/E ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83. The business has a 50-day moving average price of $72.09 and a two-hundred day moving average price of $71.07.

Cooper Companies (NASDAQ:COO – Get Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter last year, the firm earned $0.96 EPS. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Citigroup reiterated a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Finally, Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $81.64.

Read Our Latest Report on Cooper Companies

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Featured Stories

• Five stocks we like better than Cooper Companies
• Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
• Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
• Snowflake Could Be Headed for New Highs Despite Insider Selling
• MongoDB Is Surging—And the Next Catalyst Is Almost Here

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).